IX Biopharma
UEI: UJ73DZNC8HW4
• CAGE: Q4132
Overview
Awardee Type
Parent
Name
IX Biopharma
Headquarters
Singapore
Singapore
Singapore
Most Recent Award
Feb. 9, 2026
Calculating
Federal contract recipient
IX BIOPHARMA LTD.
(UEI UJ73DZNC8HW4, CAGE Q4132)
is headquartered in Singapore None.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in May 2004 and
federally registered in
December 2025.
Federal Award Analysis
IX Biopharma federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
IX BIOPHARMA LTD.
UEI
UJ73DZNC8HW4
CAGE Code
Q4132
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 8, 2004
Initial Registration
Dec. 21, 2025
Last Registration
Feb. 23, 2026
Registration Activation
Feb. 23, 2026
Registration Expiration
Feb. 23, 2027
Fiscal Year End
June 30
Reported Entity Types
For Profit Organization
Manufacturer of Goods
Manufacturer of Goods
Country of Incorporation
SGP
Employees
<500
Reported NAICS
Accepts Credit Cards
No